GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Justera Health Ltd (OTCPK:SCRSF) » Definitions » Gross Margin %

Justera Health (Justera Health) Gross Margin % : 72.29% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Justera Health Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Justera Health's Gross Profit for the three months ended in Sep. 2023 was $0.25 Mil. Justera Health's Revenue for the three months ended in Sep. 2023 was $0.35 Mil. Therefore, Justera Health's Gross Margin % for the quarter that ended in Sep. 2023 was 72.29%.


The historical rank and industry rank for Justera Health's Gross Margin % or its related term are showing as below:

SCRSF' s Gross Margin % Range Over the Past 10 Years
Min: 17.57   Med: 17.57   Max: 39.06
Current: 39.06


During the past 3 years, the highest Gross Margin % of Justera Health was 39.06%. The lowest was 17.57%. And the median was 17.57%.

SCRSF's Gross Margin % is ranked worse than
58.77% of 211 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.55 vs SCRSF: 39.06

Justera Health had a gross margin of 72.29% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Justera Health was 0.00% per year.


Justera Health Gross Margin % Historical Data

The historical data trend for Justera Health's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Justera Health Gross Margin % Chart

Justera Health Annual Data
Trend Dec19 Dec20 Dec22
Gross Margin %
- - 17.57

Justera Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.76 40.34 17.68 26.83 72.29

Competitive Comparison of Justera Health's Gross Margin %

For the Diagnostics & Research subindustry, Justera Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Justera Health's Gross Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Justera Health's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Justera Health's Gross Margin % falls into.



Justera Health Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Justera Health's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=1.9 / 10.816
=(Revenue - Cost of Goods Sold) / Revenue
=(10.816 - 8.916) / 10.816
=17.57 %

Justera Health's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=0.3 / 0.35
=(Revenue - Cost of Goods Sold) / Revenue
=(0.35 - 0.097) / 0.35
=72.29 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Justera Health  (OTCPK:SCRSF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Justera Health had a gross margin of 72.29% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Justera Health Gross Margin % Related Terms

Thank you for viewing the detailed overview of Justera Health's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Justera Health (Justera Health) Business Description

Traded in Other Exchanges
Address
2300 Yonge Street, Suite 2802, Toronto, ON, CAN, M4P 1E4
Justera Health Ltd is a Health and Wellness management company. It provides professional health and medical solutions to Canadians with a focus on concierge medical services. It provides Screen Pro Security, Naturevan, and concierge medical services, It also offers personalized health care services such as IV vitamin therapy, personal home care, nurse care, on-call urgent medical care, nutrition, and health screening services, such as COVID-19 test ingesting.